Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

33.89
-0.4700-1.37%
Post-market: 33.920.0300+0.09%19:59 EDT
Volume:1.50M
Turnover:51.30M
Market Cap:3.95B
PE:-7.26
High:34.98
Open:34.79
Low:33.47
Close:34.36
52wk High:43.15
52wk Low:22.96
Shares:116.65M
Float Shares:110.00M
Volume Ratio:0.91
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:9.68
PE(LYR):-10.62

Loading ...

Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Oct 28, 2024

Proposed Sale Of Securities

Form 144 | Viking Therapeutics' Officer Greg Zante proposes to sell 131,687 Shares, with a total value of approximately $10.28 Million.
Oct 25, 2024

Proposed Sale Of Securities

Form 144 | Viking Therapeutics' Director Rouan Sarah Kathryn proposes to sell 11,000 shares, with a total value of approximately $889,430.
Oct 25, 2024

Proposed Sale Of Securities

Form 144 | Viking Therapeutics' Director Singleton proposes to sell 16000 shares, with a total value of approximately $1.27 Million.
Oct 23, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 23, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2024

Proposed Sale Of Securities

Form144 | Viking Therapeutics' Officer Greg Zante proposes to sell 16,136 shares, with a total value of approximately $922,232.10.
Jul 30, 2024

Proposed Sale Of Securities

Form144 | Viking Therapeutics' Officer Brian Lian proposes to sell 115,859 shares, with a total value of approximately $6.67 Million.
Jul 30, 2024

Proposed Sale Of Securities

Form144 | Viking Therapeutics' Officer Marianna Mancini proposes to sell 18,026 shares, with a total value of approximately $1.03 million.
Jul 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 25, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Major Issues Report

Form 8-K - Current report